Literature DB >> 7511405

Tumour progression of human neuroblastoma cells tagged with a lacZ marker gene: earliest events at ectopic injection sites.

N R Kleinman1, K Lewandowska, L A Culp.   

Abstract

Human Platt neuroblastoma cells were transfected with the marker gene, bacterial lacZ, to track cells at the earliest stages after ectopic injection at two different sites in athymic nude mice. Three clones (LZPt-1,-2 and -3) of differing morphologies were analysed. All clones yielded large primary tumours subcutaneously or intradermally with similar latency. While LZPt-2 and -3 clones generated well-staining primary tumours, LZPt-1 cells yielded many non-staining tumours, indicating greater instability of lacZ expression for this clone in situ (stability of lacZ expression in culture was similar for all three clones). After s.c. or intradermal injections, tumour cells were tracked for 1 h to > 3 weeks (palpable) to evaluate the topology and population expansion characteristics at the earliest times. From 1 h to 2 days, tumour cells were concentrated in central masses with 'crinkly hair' distributions emanating from the periphery. Between 3 and 7 days, these 'crinkly hair' patterns were cleared from the tissue, leaving dense ovoid patterns of tumour cells. These concentrations of cells expanded collectively, not by division of one or a few cells, but by division of many cells. For clone LZPt-1, cells stained well with X-gal for 2-3 days; by 7 days, most cells were non-staining. Evidence suggests that lacZ expression is turned off in these tumour cells, rather than a lacZ- cell type clonally dominating the population. For all three clones, tumour cells remained rounded and did not spread in any tissue environment at all time points, indicating very different matrix adhesion mechanisms operating in situ compared with their distinctive spreading patterns in culture. Angioneogenesis near primary tumours became evident by 2-3 days, leading to extensive vascularisation by 1-2 weeks. Overall, these studies indicate common tumour progression characteristics for three different clones of human neuroblastoma, insight into lacZ instability mechanisms operating in one of these clones and the earliest events in primary tumour formation for this tumour at two different ectopic sites.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511405      PMCID: PMC1968801          DOI: 10.1038/bjc.1994.129

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  40 in total

1.  Bacterial lacZ gene as a highly sensitive marker to detect micrometastasis formation during tumor progression.

Authors:  W C Lin; T P Pretlow; T G Pretlow; L A Culp
Journal:  Cancer Res       Date:  1990-05-01       Impact factor: 12.701

2.  Attachment of neuroblastoma cells to extracellular matrix: correlation with metastatic capacity.

Authors:  R Hutchinson; S Fligiel; J Appleyard; J Varani; M Wicha
Journal:  J Lab Clin Med       Date:  1989-05

3.  International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma.

Authors:  G M Brodeur; R C Seeger; A Barrett; R P Castleberry; G D'Angio; B De Bernardi; A E Evans; M Favrot; A I Freeman; G Haase
Journal:  Prog Clin Biol Res       Date:  1988

4.  Human neuroblastoma metastases in a nude mouse model: tumor progression and onc gene amplification.

Authors:  F Gilbert; K L Tsao; F LaLatta; L Xu; V R Potluri; G LaBadie
Journal:  Prog Clin Biol Res       Date:  1988

5.  Tumor heterogeneity: biological implications and therapeutic consequences.

Authors:  G H Heppner; B E Miller
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

6.  Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants.

Authors:  W J Rettig; B A Spengler; P G Chesa; L J Old; J L Biedler
Journal:  Cancer Res       Date:  1987-03-01       Impact factor: 12.701

7.  Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages.

Authors:  V Ciccarone; B A Spengler; M B Meyers; J L Biedler; R A Ross
Journal:  Cancer Res       Date:  1989-01-01       Impact factor: 12.701

8.  Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine.

Authors:  T Sugimoto; T Kato; T Sawada; Y Horii; J T Kemshead; T Hino; H Morioka; H Hosoi
Journal:  Cancer Res       Date:  1988-05-01       Impact factor: 12.701

9.  Modulation of matrix adhesive responses of human neuroblastoma cells by neighboring sequences in the fibronectins.

Authors:  G Mugnai; K Lewandowska; B Carnemolla; L Zardi; L A Culp
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

10.  Complementation of two related tumour cell classes during experimental metastasis tagged with different histochemical marker genes.

Authors:  W C Lin; K L O'Connor; L A Culp
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

View more
  2 in total

1.  Differential experimental micrometastasis to lung, liver, and bone with lacZ-tagged CWR22R prostate carcinoma cells.

Authors:  Julianne L Holleran; Carson J Miller; Nancy L Edgehouse; Theresa P Pretlow; Lloyd A Culp
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

2.  Inverse expressions of the N-myc oncogene and beta 1 integrin in human neuroblastoma: relationships to disease progression in a nude mouse model system.

Authors:  R Judware; R Lechner; L A Culp
Journal:  Clin Exp Metastasis       Date:  1995-03       Impact factor: 5.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.